Yahoo Finance

LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer and the MindBody GLP-1 System. The findings reveal that when used together in a combination known as the Healthy Weight Stack, the products not only amplify each other’s benefits, but also activate 22 new genes that target key causes of age-related organ decline to help organs stay structurally strong, support tissue cells’ regeneration and repair, and improve coordination, signaling and impulses with tissue cells and nerves. Key findings from the study highlight how the products complement and enhance each other’s individual benefits: Enhanced Antioxidant Defense: Four additional antioxidant pathways were activated; Amplified Fat Metabolism: Nine additional fat and fatty acid metabolism pathways were activated, increasing the efficacy of the MindBody GLP-1 System.

Stay Ahead of the Market:

• Discover outperforming stocks and invest smarter with Top Smart Score Stocks

• Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on LFVN:

• LifeVantage price target raised to $30 from $26 at Lake Street

• Exxon and Shell cautious on Q4, Flutter cuts guidance: Morning Buzz

• Morning Movers: AngioDynamics jumps following results and guidance raise

• LifeVantage sees Q2 revenue $67.5M, up 31% vs. last year

• LifeVantage raises FY25 revenue view $235M-$245M from $200M-$210M